Using TF-specific scores for GWAS significant RCC variants, our approach identifies trans-associated proteins, which can be interpreted as the molecular target which aggregates the effect of TF-binding alteration for RCC, highlighting it as a potential downstream target of the TF. Here, TF is linked to renal cell carcinoma.